The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism
- 12 January 1999
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1453 (1), 49-62
- https://doi.org/10.1016/s0925-4439(98)00083-0
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Release of Cytochrome c from Liver Mitochondria during Permeability TransitionBiochemical and Biophysical Research Communications, 1997
- Parkinson's Disease and Free RadicalsAnnals of the New York Academy of Sciences, 1996
- Opening of the mitochondrial permeability transition pore by uncoupling or inorganic phosphate in the presence of Ca2+ is dependent on mitochondrial‐generated reactive oxygen speciesFEBS Letters, 1996
- The mitochondrial permeability transitionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Bioenergetic and oxidative stress in neurodegenerative diseasesLife Sciences, 1995
- Mitochondrial respiratory chain inhibitors induce apoptosisFEBS Letters, 1994
- Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neuronsBiochemical and Biophysical Research Communications, 1991
- Mechanism of the neurotoxicity of MPTPFEBS Letters, 1990
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineLife Sciences, 1985